MYCN is recruited to the RASSF1A promoter but is not critical for DNA hypermethylation in neuroblastoma

Mol Carcinog. 2014 May;53(5):413-20. doi: 10.1002/mc.21994. Epub 2012 Dec 31.

Abstract

Tumor suppressor genes such as RASSF1A are often epigenetically repressed by DNA hypermethylation in neuroblastoma, where the MYCN proto-oncogene is frequently amplified. MYC has been shown to associate with DNA methyltransferases, thereby inducing transcriptional repression of target genes, which suggested that MYCN might play a similar mechanistic role in the hypermethylation of tumor suppressor genes in neuroblastoma. This study tested that hypothesis by using co-immunoprecipitation and ChIP to investigate MYCN-DNA methyltransferase interactions, together with MYCN knock-down and over-expression systems to examine the effect of MYCN expression changes on gene methylation, employing both candidate gene and genome-wide assays. We show that MYCN interacts with DNA methyltransferases and is recruited to the promoter region of RASSF1A. However, using four model systems, we showed that long-term silencing of MYCN induces only a small loss of DNA methylation at the RASSF1A promoter in MYCN amplified neuroblastoma cell lines and over-expression of MYCN does not induce any DNA methylation, suggesting that MYCN is not critical for DNA hypermethylation in neuroblastoma.

Keywords: DNA hypermethylation; MYCN; epigenetics; neuroblastoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Western
  • Chromatin Immunoprecipitation
  • DNA (Cytosine-5-)-Methyltransferase 1
  • DNA (Cytosine-5-)-Methyltransferases / metabolism
  • DNA Methylation*
  • DNA Methyltransferase 3A
  • DNA, Neoplasm / genetics*
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Immunoprecipitation
  • N-Myc Proto-Oncogene Protein
  • Neuroblastoma / genetics*
  • Neuroblastoma / pathology
  • Nuclear Proteins / antagonists & inhibitors
  • Nuclear Proteins / genetics*
  • Nuclear Proteins / metabolism
  • Oncogene Proteins / antagonists & inhibitors
  • Oncogene Proteins / genetics*
  • Oncogene Proteins / metabolism
  • Polymerase Chain Reaction
  • Promoter Regions, Genetic / genetics*
  • Proto-Oncogene Mas
  • RNA, Small Interfering / genetics
  • Tumor Cells, Cultured
  • Tumor Suppressor Proteins / genetics*

Substances

  • DNA, Neoplasm
  • DNMT3A protein, human
  • MAS1 protein, human
  • MYCN protein, human
  • N-Myc Proto-Oncogene Protein
  • Nuclear Proteins
  • Oncogene Proteins
  • Proto-Oncogene Mas
  • RASSF1 protein, human
  • RNA, Small Interfering
  • Tumor Suppressor Proteins
  • DNA (Cytosine-5-)-Methyltransferase 1
  • DNA (Cytosine-5-)-Methyltransferases
  • DNA Methyltransferase 3A